medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2005, Number 4

<< Back Next >>

Rev Mex Urol 2005; 65 (4)

Prostate biopsias in patients over 80 years. Is it worth while?

Flores TJE, Varela HPE, Hernández LJM, Flores EJE, González AMC, Correa GL

Language: Spanish
References: 16
Page: 248-252
PDF size: 64.31 Kb.


ABSTRACT

Background. The risk of prostate cancer increases with age. Objectives. Understand the medical criteria for prostate biopsies in patients over 80 years of age. Material and methods. A survey was performed on 50 urologists, 50 no-urologist physicians and 50 non-physician men with the question: Do you consider convenient to perform prostate biopsies in patients over 80 years of age who are suspected of having prostate cancer? Results. Forty two of the urologists do not recommend biopsy performance, 27 non urologists physicians recommended biopsy performance and 39 non physician men agree in biopsy performance. Discussion. All patients have the right to receive adequate medical attention. In Mexico, the population index is changing with more people over 55 years of age. Conclusion. The arguments for and against prostate biopsy in patients over 80 years of age should be discussed with the patient and his family.


REFERENCES

  1. Krongrad A, Lai H, Lamm SH, Lai S. Mortality in prostate cancer. J Urol 1996; 156(3): 1084-91.

  2. Jemal A, Murray T, Samuels A, et al. Cancer statistics 2003. CA Cancer J Clin 2003; 53: 5-26.

  3. Levi F, Lucchini F, Negri E, Boyle P, Vecchia C. Changed trends of cancer mortality in the elderly. Annals of Oncology 2001; 12(10): 1467-77.

  4. Sirovich BE, Schwartz LM, Woloshin J. Screening men for prostate and colorectal cancer in the United States: Does practice reflect the evidence? JAMA 2003; 289(11): 1414-20.

  5. Reiter RE, DeKernion JB. Epidemiology, etiology and prevention of prostate cancer. Eight edition. In: Campbell Urology. Philadelphia: WB Saunders; 2002, p. 3003-24.

  6. Breslow N, Chang CW, Dhom G, et al. Latent carcinoma of the prostate at autopsy in seven areas. Int J Cancer 1977; 20: 680.

  7. Wilson SS, Crawford ED. Screening for prostate cancer: current recommendations. Urol Clin of North Am 2004; 31(2): 219-26.

  8. Terris MK. Ultrasonography and biopsy of the prostate. Eight edition. In: Campbell Urology. Philadelphia: WB Saunders; 2002, p. 3038-54.

  9. Chapple CR. Flutamide versus orchiectomy in the treatment of metastatic prostate carcinoma. Curr Opin Urol 1998; 8(4): 341-2.

  10. 10.Melton LJ, Alothman KI, Khoslas S, Achenbach SJ, Oberg AL, Zincke H. Fracture risk following bilateral orquiectomy. J Urol 2003; 169(5): 1747-50.

  11. 11.Kessler B, Albertsen P. The natural history of prostate cancer. Urol Clin North Am 2003; 30: 219-26.

  12. 12.D’Amico AV, Chen MH, Roehl KA, Catalona WJ. Preoperative psa velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 2004; 351(2): 125-35.

  13. 13.Neulander EZ, Duncan RL, Tiguert R, Poseg JT, Soloway MS. Deferred treatment of localized prostate cancer in the elderly: The impact of the age and stage at the time of diagnosis on the treatment decision. BJU International 2000; 85(6): 699-704.

  14. 14.Dreicer R, Cooper CS, Williams RD. Tratamiento del cáncer de próstata y de vejiga urinaria en el anciano. Clin Urol Nort Am 1996; 1: 97-108.

  15. 15.Fuente: Estimaciones del Consejo Nacional de Población. Primera edición, Diciembre 2002

  16. 16.Programa de acción: Cáncer de próstata. Programa Nacional de Salud 2001-2006. Secretaría de Salud. Primera edición 2001.




2020     |     www.medigraphic.com